| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.43 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.18 | 0.07 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.3 |